| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/30/2003 | EP1330475A2 Neuromedin u delta polypeptides |
| 07/30/2003 | EP1330469A2 Glycoproteins and methods of use therefof |
| 07/30/2003 | EP1330264A2 Vaccine for treating allergy |
| 07/30/2003 | EP1330263A2 Method for down-regulating ige |
| 07/30/2003 | EP1080112B1 Method for separating and/or isolating plasma proteins by annularchromatography |
| 07/30/2003 | EP1068530A4 Diagnostic for metastatic prostate cancer |
| 07/30/2003 | EP0859628B1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 07/30/2003 | EP0837694B1 Leptospira membrane proteins |
| 07/30/2003 | CN1433482A Method of testing remedy or preventive for hyperlipemia |
| 07/30/2003 | CN1433471A 85Kgda neisserial antigen |
| 07/30/2003 | CN1433470A Neisserial antigenic peptides |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1433430A Hepatitis virus sentinel virus I (SVI) |
| 07/30/2003 | CN1433321A Vaccine for prevention and treatment of Alzhermer's and amyloid related diseases |
| 07/30/2003 | CN1433318A Vascular endothelial growth factor-2 |
| 07/30/2003 | CN1432578A Recombinant protein A gene and prepn and application of its expression product |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600023 Antibody directed against HIV-1 P25 antigen |
| 07/29/2003 | US6600022 Monoclonal antibody for use in treatment and preventon of autoimmune and allergic disease |
| 07/29/2003 | US6600019 Polypeptides and nucleic acids encoding same |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6599912 Methods and compositions for modulating cell proliferation and cell death |
| 07/29/2003 | US6599873 Proteins are co-mitogens (with phytohemaglutinin) for T-cells, cause both fibroblasts and chondrocytes to secrete latent collagenase, and increase the surface adhesive powers of endothelial cells for neutrophils |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599716 Nucleic acids encoding NTR3, a member of the TNF-receptor supergene family |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599697 Generation of phagemid library; provide genes coding antibodies, incubate with recombinase, recover vectors |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | US6599495 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2146965C Cyclin complex rearrangement and uses related thereto |
| 07/29/2003 | CA2134092C Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| 07/29/2003 | CA2133838C Immunotoxins directed against cd33 related surface antigens |
| 07/29/2003 | CA2132982C Catalytic antibodies against cocaine and methods of using and producing same |
| 07/29/2003 | CA2122044C Hiv immunotherapeutics |
| 07/29/2003 | CA2069481C Purified igc immunoglobulins |
| 07/29/2003 | CA2053586C Defined culture medium for cho cells |
| 07/29/2003 | CA2012125C Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy |
| 07/29/2003 | CA1341435C Recombinant pox virus for immunization against tumor-associated antigens |
| 07/24/2003 | WO2003060465A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| 07/24/2003 | WO2003060150A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060148A2 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/24/2003 | WO2003060143A2 Efficient protein expression system |
| 07/24/2003 | WO2003060097A2 USE OF SOLUBLE Ϝδ T CELL RECEPTORS FOR REGULATING T CELL FUNCTION |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060080A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 07/24/2003 | WO2003059953A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 07/24/2003 | WO2003059952A1 Bispecific antibody dna constructs for intramuscular administration |
| 07/24/2003 | WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | WO2003059941A1 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/24/2003 | WO2003059935A2 Methods for purifying protein |
| 07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003059879A2 Method of inhibiting atherosclerotic plaque destabilization |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | WO2003059290A2 Diagnostic and therapeutic uses of topors |
| 07/24/2003 | WO2003059282A2 Human monoclonal antibodies against cd30 |
| 07/24/2003 | WO2003059273A2 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/24/2003 | WO2003059260A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 07/24/2003 | WO2003059259A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 07/24/2003 | WO2003059257A2 Anti-angiogenic proteins and fragmentsand methods of use thereof |
| 07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | WO2003059251A2 Antibody targeting compounds |
| 07/24/2003 | WO2003059245A2 Method of treating asthma |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003018612A3 Extracellular messengers |
| 07/24/2003 | WO2003000714A3 Compositions and methods for preventing protein aggregation in neurodegenerative diseases |
| 07/24/2003 | WO2002102839A3 Novel g-protein coupled receptors and dna sequences thereof |
| 07/24/2003 | WO2002088358A3 Human fibroblast growth factor-related compositions |
| 07/24/2003 | WO2002088307A3 Humanized antibodies |
| 07/24/2003 | WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
| 07/24/2003 | WO2002059323A3 Aminoacyl trna synthetases |
| 07/24/2003 | WO2002055718A3 Assembly and screening of highly complex and fully human antibody repertoire in yeast |
| 07/24/2003 | WO2002052018A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/24/2003 | WO2002022687A3 Viral chemokine-tumur antigen fusion proteins |
| 07/24/2003 | WO2002018954A3 Inhibition of cmv infection and dissemination |
| 07/24/2003 | US20030140370 Fungal glyoxal oxidases |
| 07/24/2003 | US20030140363 Expression vector comprising hydrolase regulatory sequences, matrix attachment region (MAR) and transcriptional enhancer for use as gene transfer tools |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139581 Protocadherin materials and methods |
| 07/24/2003 | US20030139580 Tumour necrosis factor binding ligands |
| 07/24/2003 | US20030139579 LO-CD2b antibody and uses thereof for inhibiting T cell activation and proliferation |
| 07/24/2003 | US20030139577 Tumour necrosis factor binding ligands |
| 07/24/2003 | US20030139575 Cytokine immunoconjugates |
| 07/24/2003 | US20030139573 Lipid binding protein 3 |
| 07/24/2003 | US20030139571 G protein-coupled chemokine receptor for prevention and detection of viral infection; viricides |
| 07/24/2003 | US20030139374 Combined methods for tumor vasculature coagulation and treatment |
| 07/24/2003 | US20030139348 Animal growth regulators |
| 07/24/2003 | US20030139330 Transcription factors containing two potential dna binding motifs |
| 07/24/2003 | US20030139329 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030139328 Complexing; modulating biological activation |
| 07/24/2003 | US20030138972 Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 07/24/2003 | US20030138932 Comprises enzymatic glycoproteins for use as antitumor/antiproliferative agents; enzyme inhibitors; drug screening |